Company Ticker News July 7, 2021Merck's (MRK) Keytruda Gets FDA Nod for Advanced Skin Cancer 0 0 Share
Press Release July 1, 2021Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Third-Line Gastric Cancer in the US 0 0 Share
Company Ticker News July 1, 2021NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular & Metabolic Targets 0 0 Share
Company Ticker News July 1, 2021Alpine (ALPN) Enters Immuno-Oncology Collaboration With Merck 0 0 Share
Company Ticker News July 1, 2021Merck's new CEO Robert Davis begins, after Ken Frazier's retirement 0 0 Share
Company Ticker News July 1, 2021Merck's (MRK) Keytruda Gets Nod for Esophageal Cancer in EU (Revised) 0 0 Share